Literature DB >> 25017033

Potent and selective inhibitors of the TASK-1 potassium channel through chemical optimization of a bis-amide scaffold.

Daniel P Flaherty1, Denise S Simpson1, Melissa Miller2, Brooks E Maki1, Beiyan Zou2, Jie Shi2, Meng Wu3, Owen B McManus3, Jeffrey Aubé1, Min Li2, Jennifer E Golden4.   

Abstract

TASK-1 is a two-pore domain potassium channel that is important to modulating cell excitability, most notably in the context of neuronal pathways. In order to leverage TASK-1 for therapeutic benefit, its physiological role needs better characterization; however, designing selective inhibitors that avoid the closely related TASK-3 channel has been challenging. In this study, a series of bis-amide derived compounds were found to demonstrate improved TASK-1 selectivity over TASK-3 compared to reported inhibitors. Optimization of a marginally selective hit led to analog 35 which displays a TASK-1 IC50=16 nM with 62-fold selectivity over TASK-3 in an orthogonal electrophysiology assay.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bis-amide; KCNK3; Selective potassium channel inhibitor; TASK1

Mesh:

Substances:

Year:  2014        PMID: 25017033      PMCID: PMC4160056          DOI: 10.1016/j.bmcl.2014.06.032

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  39 in total

1.  TASK-3, a new member of the tandem pore K(+) channel family.

Authors:  Y Kim; H Bang; D Kim
Journal:  J Biol Chem       Date:  2000-03-31       Impact factor: 5.157

Review 2.  TASK-1 is a highly modulated pH-sensitive 'leak' K(+) channel expressed in brainstem respiratory neurons.

Authors:  D A Bayliss; E M Talley; J E Sirois; Q Lei
Journal:  Respir Physiol       Date:  2001-12

3.  Characterization of potassium channel modulators with QPatch automated patch-clamp technology: system characteristics and performance.

Authors:  Jonatan Kutchinsky; Søren Friis; Margit Asmild; Rafael Taboryski; Simon Pedersen; Ras K Vestergaard; Rasmus B Jacobsen; Karen Krzywkowski; Rikke L Schrøder; Trine Ljungstrøm; Nathalie Hélix; Claus B Sørensen; Morten Bech; Niels J Willumsen
Journal:  Assay Drug Dev Technol       Date:  2003-10       Impact factor: 1.738

4.  TWIK-related acid-sensitive K+ channel 1 (TASK1) and TASK3 critically influence T lymphocyte effector functions.

Authors:  Sven G Meuth; Stefan Bittner; Patrick Meuth; Ole J Simon; Thomas Budde; Heinz Wiendl
Journal:  J Biol Chem       Date:  2008-03-28       Impact factor: 5.157

5.  Cloning and expression of a novel pH-sensitive two pore domain K+ channel from human kidney.

Authors:  R Reyes; F Duprat; F Lesage; M Fink; M Salinas; N Farman; M Lazdunski
Journal:  J Biol Chem       Date:  1998-11-20       Impact factor: 5.157

Review 6.  From the background to the spotlight: TASK channels in pathological conditions.

Authors:  Stefan Bittner; Thomas Budde; Heinz Wiendl; Sven G Meuth
Journal:  Brain Pathol       Date:  2010-11       Impact factor: 6.508

7.  Endothelin-1 inhibits background two-pore domain channel TASK-1 in primary human pulmonary artery smooth muscle cells.

Authors:  Bi Tang; Yingji Li; Chandran Nagaraj; Rory E Morty; Sabine Gabor; Elvira Stacher; Robert Voswinckel; Norbert Weissmann; Katharina Leithner; Horst Olschewski; Andrea Olschewski
Journal:  Am J Respir Cell Mol Biol       Date:  2009-02-02       Impact factor: 6.914

8.  TASK channel deletion in mice causes primary hyperaldosteronism.

Authors:  Lucinda A Davies; Changlong Hu; Nick A Guagliardo; Neil Sen; Xiangdong Chen; Edmund M Talley; Robert M Carey; Douglas A Bayliss; Paula Q Barrett
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-04       Impact factor: 11.205

Review 9.  Therapeutic potential of neuronal two-pore domain potassium-channel modulators.

Authors:  Alistair Mathie; Emma L Veale
Journal:  Curr Opin Investig Drugs       Date:  2007-07

10.  The pungent substances piperine, capsaicin, 6-gingerol and polygodial inhibit the human two-pore domain potassium channels TASK-1, TASK-3 and TRESK.

Authors:  Leopoldo R Beltrán; Corinna Dawid; Madeline Beltrán; Guenter Gisselmann; Katharina Degenhardt; Klaus Mathie; Thomas Hofmann; Hanns Hatt
Journal:  Front Pharmacol       Date:  2013-11-18       Impact factor: 5.810

View more
  18 in total

1.  Breathing Stimulant Compounds Inhibit TASK-3 Potassium Channel Function Likely by Binding at a Common Site in the Channel Pore.

Authors:  Rikki H Chokshi; Aaron T Larsen; Brijesh Bhayana; Joseph F Cotten
Journal:  Mol Pharmacol       Date:  2015-08-12       Impact factor: 4.436

Review 2.  High throughput screening technologies for ion channels.

Authors:  Hai-bo Yu; Min Li; Wei-ping Wang; Xiao-liang Wang
Journal:  Acta Pharmacol Sin       Date:  2015-12-14       Impact factor: 6.150

Review 3.  Investigational antiarrhythmic agents: promising drugs in early clinical development.

Authors:  Jordi Heijman; Shokoufeh Ghezelbash; Dobromir Dobrev
Journal:  Expert Opin Investig Drugs       Date:  2017-07-20       Impact factor: 6.206

4.  pH-dependent inhibition of K₂P3.1 prolongs atrial refractoriness in whole hearts.

Authors:  Mark A Skarsfeldt; Thomas A Jepps; Sofia H Bomholtz; Lea Abildgaard; Ulrik S Sørensen; Emilie Gregers; Jesper H Svendsen; Jonas G Diness; Morten Grunnet; Nicole Schmitt; Søren-Peter Olesen; Bo H Bentzen
Journal:  Pflugers Arch       Date:  2016-01-05       Impact factor: 3.657

Review 5.  Mechanisms and Drug Development in Atrial Fibrillation.

Authors:  David Calvo; David Filgueiras-Rama; José Jalife
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

6.  TALK-1 channels control β cell endoplasmic reticulum Ca2+ homeostasis.

Authors:  Nicholas C Vierra; Prasanna K Dadi; Sarah C Milian; Matthew T Dickerson; Kelli L Jordan; Patrick Gilon; David A Jacobson
Journal:  Sci Signal       Date:  2017-09-19       Impact factor: 8.192

Review 7.  The CNS under pathophysiologic attack--examining the role of K₂p channels.

Authors:  Petra Ehling; Manuela Cerina; Thomas Budde; Sven G Meuth; Stefan Bittner
Journal:  Pflugers Arch       Date:  2014-12-09       Impact factor: 3.657

8.  Crosstalk between KCNK3-Mediated Ion Current and Adrenergic Signaling Regulates Adipose Thermogenesis and Obesity.

Authors:  Yi Chen; Xing Zeng; Xuan Huang; Sara Serag; Clifford J Woolf; Bruce M Spiegelman
Journal:  Cell       Date:  2017-10-05       Impact factor: 41.582

9.  Circadian photoperiod alters TREK-1 channel function and expression in dorsal raphe serotonergic neurons via melatonin receptor 1 signaling.

Authors:  Manuel A Giannoni-Guzmán; Anna Kamitakahara; Valerie Magalong; Pat Levitt; Douglas G McMahon
Journal:  J Pineal Res       Date:  2020-12-12       Impact factor: 13.007

10.  ML365 inhibits TWIK2 channel to block ATP-induced NLRP3 inflammasome.

Authors:  Xiao-Yan Wu; Jin-Yan Lv; Shi-Qing Zhang; Xin Yi; Zi-Wei Xu; Yuan-Xing Zhi; Bo-Xin Zhao; Jian-Xin Pang; Ken Kin Lam Yung; Shu-Wen Liu; Ping-Zheng Zhou
Journal:  Acta Pharmacol Sin       Date:  2021-08-02       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.